Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta‐analysis

• Váldodahkkit: Yukinori Takenaka (Dahkki), Ryohei Oya (Dahkki), Norihiko Takemoto (Dahkki), Hidenori Inohara (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Wiley, 2021-10-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Sarcopenia, which is characterized by a decrease in muscle quantity or quality, is commonly observed in patients with cancer. Recent research has reported contradictory results on the association between sarcopenia and the efficacy of immune checkpoint inhibitors (ICIs). We conducted a syst...